CXCL9 anticorps (AA 23-125)

N° du produit ABIN741930

Cité dans 8 publications. Cet anticorps anti-CXCL9 Polyclonal Lapin (ABIN741930) détecte spécifiquement CXCL9 dans WB, ELISA, IHC (p), IF (cc), IF (p) et IHC (fro). L’anticorps est réactif avec des échantillons de Humain, Souris, Rat et Porc.

Aperçu rapide pour CXCL9 anticorps (AA 23-125) (ABIN741930)

Antigène: CXCL9 (gamma-Interferon-Induced Monokine (CXCL9))

Reactivité: Humain, Souris, Rat, Porc

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CXCL9 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Détail du produit anti-CXCL9 anticorps

Épitope: AA 23-125

Réactivité croisée: Humain, Souris, Porc, Rat

Homologie: Cow,Horse

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human CXCL9

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Date de péremption: 12 months

Références pour anticorps anti-CXCL9 (ABIN741930)

Lee, Cho, Cho, Bae, Kim, Park: "Establishment of a chronic obstructive pulmonary disease mouse model based on the elapsed time after LPS intranasal instillation." dans: Laboratory animal research, Vol. 34, Issue 1, pp. 1-10, (2018) (PubMed).

Shimoura, Nagai, Fujiwara, Jimbo, Yoshimoto, Nishigori: "Interleukin (IL)-18, cooperatively with IL-23, induces prominent inflammation and enhances psoriasis-like epidermal hyperplasia." dans: Archives of dermatological research, Vol. 309, Issue 4, pp. 315-321, (2017) (PubMed).

Yada, Iimuro, Uyama, Uda, Okada, Fujimoto: "Splenectomy attenuates murine liver fibrosis with hypersplenism stimulating hepatic accumulation of Ly-6C(lo) macrophages." dans: Journal of hepatology, Vol. 63, Issue 4, pp. 905-16, (2016) (PubMed).

Sawano, Shimizu, Yamada, Nanashima, Miura, Morohashi, Kudo, Hui, Kijima, Hakamada, Tsuchida: "Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan." dans: Oncology reports, Vol. 33, Issue 5, pp. 2151-60, (2015) (PubMed).

Zhang, Hu, Liu, Ye, Gui, Zhou, Qi, He, Wang, Wang: "CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment." dans: Scientific reports, Vol. 5, pp. 15948, (2015) (PubMed).

Cai, Jiang, Pan, Chen, Zhang, Zhu, Cai, Ling, Chen, Xu, Chen: "Transcriptomic analysis of hepatic responses to testosterone deficiency in miniature pigs fed a high-cholesterol diet." dans: BMC genomics, Vol. 16, pp. 59, (2015) (PubMed).

Clancy-Thompson, Perekslis, Croteau, Alexander, Chabanet, Turk, Huang, Mullins: "Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease." dans: Cancer immunology research, Vol. 3, Issue 8, pp. 956-67, (2015) (PubMed).

Détails sur CXCL9

Antigène: CXCL9 (gamma-Interferon-Induced Monokine (CXCL9))

Autre désignation: CXCL9/MIG

Sujet:

Synonyms: CMK, MIG, Humig, SCYB9, crg-1, C-X-C motif chemokine 9, Gamma-interferon-induced monokine, Monokine induced by interferon-gamma, Small-inducible cytokine B9, CXCL9

Background: Cytokine that affects the growth, movement, or activation state of cells that participate in immune and inflammatory response. Chemotactic for activated T-cells. Binds to CXCR3.

ID gène: 4283

UniProt: Q07325